RMPs have comparable clinical outcomes to non-RMPs. (A) Best response according to RMP status. (B-D) PFS according to RMPs in the general population (B), cilta-cel (C), and ide-cel (D). (E) Univariate logistic regression for progression. (F) Multivariate logistic regression for progression of disease. (G) OS according to RMPs in the general population. (H) CRS of any grade according to RMP status. (I) CRS severity (grade ≥3) according to RMP status. (J) ICANS any grade according to RMP status. (K-M) ANC, PLTS, and Hb from day 0 to month 6 according to RMP status. (N-O) CRP and ferritin according to RMP status. Univariate and multivariate analyses for progression were performed using logistic regression. Comparisons between proportions were conducted using Fisher exact test. Longitudinal blood count values were analyzed using nonparametric tests. ANC, absolute neutrophil count; ASCT, autologous stem cell transplant; CRP, C-reactive protein; G1,grade 1; G2, grade 2; G3, grade 3; G4, grade 4; Hb, hemoglobin; n.v., normal value range; ns, not significant; PLTS, platelets; R-ISS, Revised International Staging System; SD/PD, stable disease/progressive disease.